KATHERINE KEMPER-DEAN: Open Payments
NPI 1376863837 · OLNEY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$525 in 26 payments from 12 companies in 2025. Trend: 2023 $449 · 2024 $591 · 2025 $525
Food & beverage: $525
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $89 |
| PFIZER INC. | 4 | $88 |
| Novo Nordisk Inc | 4 | $86 |
| Astellas Pharma US Inc | 2 | $52 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Abbott Laboratories | 2 | $41 |
| ABBVIE INC. | 1 | $22 |
| Bausch Health US, LLC | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
Products named: NURTEC ODT, EVENITY, Veozah, Wegovy, FREESTYLE LIBRE 3, SHINGRIX, OTEZLA, Rybelsus.
Industry payments across MD — which companies pay providers there.
